Laura Rezac
MOHS-Micrographic Surgery · Roseville, MNNPI 1578182911
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Boehringer Ingelheim accounts for 65.3% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2022 at $6,918 and has fallen 94.9% since, to $353 in 2025. Among mohs-micrographic surgery clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 100 payments — averaging $146.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$10K
- AbbVie$1K
- Sanofi$887
- E.r. Squibb & Sons, L.L.C.$697
- Dermavant Sciences, Inc.$464
- Lilly USA, LLC$287
- plus $2K from 17 others
What the payments were for
- Consulting fees$5,74039%
- Speaking & faculty fees$1,91413%
- Travel & lodging$1,46110%
- Food & beverage$5,41537%
- Education$1231%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 14 | $9,572 |
| AbbVie | 26 | $1,043 |
| Sanofi | 8 | $887 |
| E.r. Squibb & Sons, L.L.C. | 9 | $697 |
| Dermavant Sciences, Inc. | 4 | $464 |
| Lilly USA, LLC | 7 | $287 |
| Incyte Corporation | 2 | $253 |
| Johnson & Johnson | 4 | $154 |
| Janssen Scientific Affairs, LLC | 5 | $132 |
| Revance Therapeutics, Inc. | 1 | $131 |
| Kyowa Kirin, Inc. | 3 | $129 |
| Novartis | 2 | $126 |
| Amgen | 1 | $124 |
| Amryt Pharma Holdings Ltd | 1 | $106 |
| Mallinckrodt Hospital Products Inc. | 2 | $105 |
| Galderma Laboratories, L.p. | 1 | $101 |
| Pfizer | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 1 | $94 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $53 |
| LEO Pharma Inc. | 2 | $30 |
| Almirall LLC | 1 | $29 |
| Urgo Medical North America, LLC | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,653 in reported general payments places this provider in the 95th percentile of 29 mohs-micrographic surgery providers in Minnesota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 20 | $70,957 |
| Clobetasol Propionate | 17 | $731 |
| Ketoconazole | 26 | $473 |
| Triamcinolone Acetonide | 24 | $399 |
| Doxycycline Hyclate | 18 | $238 |
| CiclopiroxCiclopirox Olamine | 13 | $131 |
| MethotrexateMethotrexate Sodium | 12 | $106 |
| Cephalexin | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Roseville
- Munir IdrissRoseville$444
- Ian MaherMinneapolis$18K
- Edward SegerPlymouth$4K
- Addison DemerRochester$4K
- Anna-Bianca StashakRochester$902
- Ryan LaddRochester$808
- Bart EndrizziFridley$762
- Elliott CampbellRochester$732
- Chandler RundleMinneapolis$652
- Julie CronkSaint Paul$523
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.